Preclinical studies have validated the therapeutic potential of these compounds for the treatment of obesity and diabetes
With the increasing prevalence of metabolic diseases globally, interventions targeting GLP-1R could play an important role in reducing the burden of these conditions
DOI: 10.1038/s41598-018-32032-x, Wicinski, M., Gebalski, J., Golebiewski, J., and Malinowski, B
Excess weight, in and of itself, is not a disease. When it comes to her patients, she says, shes a stickler for a holistic approach to health, including eating a nutritious diet (not just eating less) and daily physical activity, as essential elements of the weight-loss process
People taking FDA-approved doses of Wegovy for one year and four months lost about 35 pounds, according to the manufacturer